Incidence and indicators of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialized countries: Results from the EXPLORE study

Jesus Kazuo Yamamoto-Furusho  1     Othman Al Harbi  2     Webber Chan  3     Enrique Ponce de Leon  4     Jiaming Qian  5     Marina V. Shapina  6     Murat Toruner     Chia-Hung Tu     Byong Duk Ye     Morgane Guennec     Cecilia Sison     Dirk Demuth     Olga Fadeeva     Qasim M Rana-Khan     Alessandro Armuzzi    
1 IBD Clinic, Dept. of Endoscopy,Mexico,Mexico
2 King Khalid University Hospital, King Saud University,Riyadh,Saudi Arabia
3 Singapore General Hospital,Singapore,Singapore
4 Fundaci√≥n Cardio Infantil, Instituto de Cardiolog√≠a,Bogota,Colombia
5 Peking Union Medical College Hospital,Beijing,China
6 Inflammatory and Functional Bowel Diseases Re

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing